Octave Bioscience Patents – Insights & Stats (Updated 2023)

Octave Bioscience has a total of 24 patents globally, out of which 2 have been granted. Of these 24 patents, more than 87% patents are active. The US, Canada & Europe (EPO) is where Octave Bioscience has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Octave Bioscience and is also the origin country of the firm.

Octave Bioscience was founded in the year 2014 by Melinda Thomas and William Hagstrom. The company is a biotechnology firm that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Do read about some of the most popular patents of Octave Bioscience which have been covered by us in this article and also you can find Octave Bioscience patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Octave Bioscience patent portfolio.

How many patents does Octave Bioscience have?

Octave Bioscience has a total of 24 patents globally. These patents belong to 7 unique patent families. Out of 24 patents, 21 patents are active.

How Many Patents did Octave Bioscience File Every Year?

Octave Bioscience Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOctave Bioscience Applications FiledOctave Bioscience Patents Granted
20222
202110
20206
2019
20181
20172
2016
2015
2014

How many Octave Bioscience patents are Alive/Dead?

Worldwide Patents

Octave Bioscience Patent Portfolio

How Many Patents did File in Different Countries?

Octave Bioscience Worldwide Patent Filing

Countries in which Octave Bioscience Filed Patents

CountryPatents
Canada4
United States Of America4
Europe4
Israel2
Brazil2
Australia2
China2
Hong Kong (S.A.R.)1

Where are Research Centres of Octave Bioscience Patents Located?

The R&D Centre of patents filed by Octave Bioscience is in the USA.

List of Octave Bioscience Patents

Octave Bioscience PatentsTitle
US11773446B2Methods For Assessment Of Multiple Sclerosis Activity
US20230290039A13D Graph Visualizations To Reveal Features Of Disease
US20230266342A1Biomarkers For Predicting Multiple Sclerosis Disease Progression
US20220187295A1Biomarkers For Predicting Multiple Sclerosis Disease Activity
EP3443125B1Methods For Assessment Of Multiple Sclerosis Activity
EP4208869A1Biomarkers For Predicting Multiple Sclerosis Disease Progression
EP4208849A13D Graph Visualizations To Reveal Features Of Disease
EP4026132A1Biomarkers For Predicting Multiple Sclerosis Disease Activity
CN116324419ABiomarker For Predicting Disease Progression Of Multiple Sclerosis
CN114730613ABiomarker For Predicting Disease Activity Of Multiple Sclerosis
CA3189918A1Biomarkers For Predicting Multiple Sclerosis Disease Progression
CA3189916A13D Graph Visualizations To Reveal Features Of Disease
CA3150154A1Biomarkers For Predicting Multiple Sclerosis Disease Activity
CA3021036A1Methods For Assessment Of Multiple Sclerosis Activity
AU2021336985A1Biomarkers For Predicting Multiple Sclerosis Disease Progression
AU2020341564A1Biomarkers For Predicting Multiple Sclerosis Disease Activity
BR112023004087A2Biomarkers To Predict Progression Of Multiple Sclerosis Disease
BR112022004094A2Biomarkers To Predict Multiple Sclerosis Disease Activity
IL300646ABiomarkers For Predicting Multiple Sclerosis Disease Progression
IL290952ABiomarkers For Predicting Multiple Sclerosis Disease Activity
HK40078438ABiomarkers For Predicting Multiple Sclerosis Disease Activity
WO2021046329A9Biomarkers For Predicting Multiple Sclerosis Disease Activity
WO2022051674A1Biomarkers For Predicting Multiple Sclerosis Disease Progression
WO2022051277A13D Graph Visualizations To Reveal Features Of Disease

What are Octave Bioscience’s key innovation segments?

What Technologies are Covered by Octave Bioscience?

The chart below distributes patents filed by Octave Bioscience in different countries on the basis of the technology protected in patents. It also represents the markets where Octave Bioscience thinks it’s important to protect particular technology inventions.

R&D Focus: How has Octave Bioscience’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Octave Bioscience?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.